Protagenic Therapeutics Inc
General ticker "PTIX" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $2.6M
Protagenic Therapeutics Inc does not follow the US Stock Market performance with the rate: -29.0%.
Estimated limits based on current volatility of 8.2%: low 0.59$, high 0.69$
Factors to consider:
- Price in estimated range
- Earnings for 9 months up through Q3 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [0.60$, 1.83$]
- 2024-12-30 to 2025-12-30 estimated range: [0.87$, 2.36$]
Financial Metrics affecting the PTIX estimates:
- Negative: Non-GAAP EPS, $ of -1.15 <= 0.10
- Negative: Operating profit margin, % of -100 <= 1.03
- Negative: Operating cash flow per share per price, % of -50.82 <= 2.35
- Negative: negative Net income
- Negative: Industry operating cash flow per share per price (median), % of -23.87 <= 3.85
- Negative: Industry operating profit margin (median), % of -98.30 <= 2.14
- Positive: Inventory ratio change, % of 0 <= 0
- Negative: Industry earnings per price (median), % of -26.04 <= 1.31
Short-term PTIX quotes
Long-term PTIX plot with estimates
Financial data
| YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|
| Operating Revenue | $0.00MM | $0.00MM | $0.00MM |
| Operating Expenses | $4.14MM | $3.56MM | $4.53MM |
| Operating Income | $-4.14MM | $-3.56MM | $-4.53MM |
| Non-Operating Income | $-0.38MM | $0.00MM | $-0.47MM |
| Interest Expense | $0.50MM | $0.14MM | $0.00MM |
| R&D Expense | $1.14MM | $1.59MM | $3.32MM |
| Income(Loss) | $-4.52MM | $-3.56MM | $-5.00MM |
| Profit(Loss) | $-4.52MM | $-3.56MM | $-5.00MM |
| Stockholders Equity | $9.94MM | $6.92MM | $3.67MM |
| Assets | $11.06MM | $8.04MM | $4.32MM |
| Operating Cash Flow | $-2.80MM | $-1.99MM | $-3.70MM |
| Capital expenditure | $0.00MM | $0.00MM | $0.15MM |
| Investing Cash Flow | $-9.91MM | $1.60MM | $4.78MM |
| Financing Cash Flow | $12.58MM | $0.07MM | $0.00MM |
| Earnings Per Share* | $-1.35 | $-0.83 | $-1.15 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.